Hyperhidrosis

NovaBay Pharmaceuticals’ DERMAdoctor Products to be Featured at Leading B2B Beauty Trade Show Cosmoprof North America

Retrieved on: 
Thursday, July 7, 2022

(NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that its DERMAdoctor product collections will be featured at Cosmoprof North America, a leading business-to-business (B2B) beauty trade show being held July 12-14 at the Las Vegas Convention Center.

Key Points: 
  • (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that its DERMAdoctor product collections will be featured at Cosmoprof North America, a leading business-to-business (B2B) beauty trade show being held July 12-14 at the Las Vegas Convention Center.
  • The DERMAdoctor team will be showcasing products that offer innovative treatments that address commonly overlooked skin concerns and target specific underserved segments of the skincare market.
  • The trade show is a powerful platform that has enjoyed the continuous support and presence of key industry entities and leading beauty associations.
  • NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets.

The Worldwide Cosmetic Surgery and Procedure Industry is Expected to Reach $107.2 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, June 3, 2022

The Global Cosmetic Surgery And Procedure Market size is expected to reach $107.2 billion by 2027, rising at a market growth of 9.8% CAGR during the forecast period.

Key Points: 
  • The Global Cosmetic Surgery And Procedure Market size is expected to reach $107.2 billion by 2027, rising at a market growth of 9.8% CAGR during the forecast period.
  • Cosmetic surgery is a specialized area of medicine that focuses on enhancing one's look through surgical and medicinal methods.
  • In addition, cosmetic surgery is opted by the people who want to increase the aesthetic appeal of a functional body part.
  • The invention of new cosmetic devices through manufactures has resulted in an increase in demand for cosmetic therapies in recent years.

Patient Safety a Growing Problem as Non-Physician Supervised Laser Centers Opening Throughout Delray Beach

Retrieved on: 
Thursday, May 19, 2022

DELRAY BEACH, Fla., May 19, 2022 /PRNewswire/ -- "There's a trend for non-dermatologist, non-plastic surgeon supervised laser centers to open and make a quick buck," says Dr. Steven Hacker, Founder of Hacker Dermatology. Dr. Hacker should know with laser experience dating back to 1992, when his groundbreaking research was first published in The Archives of Dermatology, showing pulsed dye laser worked on Psoriasis. "Just off Atlantic Avenue, laser treatments are being sold to patients at "so-called" laser centers, salons, and med spas. These centers, often motivated by profit over care, promote cosmetic laser treatments at great risk to patient's safety."

Key Points: 
  • DELRAY BEACH, Fla., May 19, 2022 /PRNewswire/ --"There's a trend for non-dermatologist, non-plastic surgeon supervised laser centers to open and make a quick buck," says Dr. Steven Hacker, Founder of Hacker Dermatology.
  • "Just off Atlantic Avenue, laser treatments are being sold to patients at "so-called" laser centers, salons, and med spas.
  • These centers, often motivated by profit over care, promote cosmetic laser treatments at great risk to patient's safety."
  • The article concluded that the safety and efficacy of the laser or light devices are ideal for achieving desired outcomes.

The Best BOTOX Seattle Offers Is At Seattle Plastic Surgery

Retrieved on: 
Thursday, April 28, 2022

SEATTLE, April 28, 2022 /PRNewswire/ -- As one of the most performed and sought after non-surgical cosmetic treatments in the world, more and more salons and clinics are offering BOTOX. However, it requires trained professionals with years of experience to provide the best results from Seattle BOTOX injections. Along with the traditional treatment of the "eleven lines" and forehead lines, the master injectors at Seattle Plastic Surgery offer masseter BOTOX, hyperhidrosis treatment, and BOTOX for migraines.

Key Points: 
  • Along with the traditional treatment of the "eleven lines" and forehead lines, the master injectors at Seattle Plastic Surgery offer masseter BOTOX, hyperhidrosis treatment, and BOTOX for migraines.
  • About Seattle Plastic Surgery: Seattle Plastic Surgery is a leading plastic surgery clinic and medical spa located in downtown Seattle.
  • Offering high-end cosmetic treatments including injectables, skincare, and plastic surgery, Seattle Plastic Surgery is the top destination for all aesthetic needs in Washington.
  • Seeing multiple BOTOX patients every week, Seattle Plastic Surgery's expertise in BOTOX injections is world class.

Axillary Hyperhidrosis Pipeline Market Research Report 2022 Featuring Brickell Biotech, Dermata Therapeutics, Eirion Therapeutics, Theravida, GlaxoSmithKline, & Medytox - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 21, 2022

The "Axillary Hyperhidrosis - Pipeline Insight, 2022" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Axillary Hyperhidrosis pipeline landscape.

Key Points: 
  • The "Axillary Hyperhidrosis - Pipeline Insight, 2022" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Axillary Hyperhidrosis pipeline landscape.
  • The assessment part of the report embraces in depth Axillary Hyperhidrosis commercial assessment and clinical assessment of the pipeline products under development.
  • The drug is currently being developed in Phase 2 stage of development for the treatment of Axillary Hyperhidrosis.
  • The companies which have their Axillary Hyperhidrosis drug candidates in the most advanced stage, i.e.

Palmar Hyperhidrosis Pipeline Market Insights Report 2022 Featuring Key Players - Atacama Therapeutics, GlaxoSmithKline, Brickell Biotech, & Candesant Biomedical - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 21, 2022

The "Palmar Hyperhidrosis - Pipeline Insight, 2022" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Palmar Hyperhidrosis pipeline landscape.

Key Points: 
  • The "Palmar Hyperhidrosis - Pipeline Insight, 2022" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Palmar Hyperhidrosis pipeline landscape.
  • A detailed picture of the Palmar Hyperhidrosis pipeline landscape is provided which includes the disease overview and Palmar Hyperhidrosis treatment guidelines.
  • The assessment part of the report embraces in depth Palmar Hyperhidrosis commercial assessment and clinical assessment of the pipeline products under development.
  • Palmar Hyperhidrosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

LiVDerm presents SBS: West Coast Derm, the latest educational dermatology event

Retrieved on: 
Wednesday, April 13, 2022

LiVDerm's SBS: West Coast Derm will take place October 14-16, 2022, at the scenic Terranea Resort in Rancho Palos Verdes, California.

Key Points: 
  • LiVDerm's SBS: West Coast Derm will take place October 14-16, 2022, at the scenic Terranea Resort in Rancho Palos Verdes, California.
  • This innovative educational experience in medical, surgical, and aesthetic dermatology has been methodically crafted with a West Coast audience in mind.
  • Attendees of SBS: West Coast Derm will learn the latest developments and strategies in medical and aesthetic dermatology principles from world-renowned experts.
  • With a multipronged approach to mastering the myriad of subspecialties within the field, LiVDerm provides innovative and integrated education across the dermatology spectrum.

MISSION PLASTICOS ANNOUNCES APPOINTMENT OF NEW RESHAPING LIVES AMERICA COUNCIL OF TRUSTEES MEMBER, N. BILL AYDIN, MD, FACS

Retrieved on: 
Monday, March 21, 2022

Reshaping Lives America will initially focus on the Reshaping Lives: Full Circle program; a partnership with Mission Plasticos and Sientra to provide breast reconstructive surgery for post-mastectomy women in the U.S. living in poverty.

Key Points: 
  • Reshaping Lives America will initially focus on the Reshaping Lives: Full Circle program; a partnership with Mission Plasticos and Sientra to provide breast reconstructive surgery for post-mastectomy women in the U.S. living in poverty.
  • "Mission Plasticos is expanding our Council of Trustees and looks forward to working with all of our partners in making a significant impact."
  • For more information on Mission Plasticos, Reshaping Lives America, and/or the Reshaping Lives America Council of Trustees, click here .
  • Its highly acclaimed Reshaping Lives California program is being expanded nationally to serve medically underserved patients in the U.S. through its Reshaping Lives America program.

Global Botulinum Toxin Market Forecast to 2028 - by Product Type, Application, and End User - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 16, 2022

The "Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, and End User" report has been added to ResearchAndMarkets.com's offering.
  • The botulinum toxin market is expected to reach US$ 8,977.62 million by 2028 from US$ 5,307.71 million in 2021.
  • The factors responsible for the botulinum toxin market's growth are increasing aesthetic procedures and the use of botulinum toxin, and the rising number of non-invasive cosmetic procedures.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global botulinum toxin market.

Palmar Hyperhidrosis Epidemiology Forecasts Research Report 2019-2021 & 2022-2032 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 2, 2022

The "Palmar Hyperhidrosis - Epidemiology Forecast to 2032 (US)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Palmar Hyperhidrosis - Epidemiology Forecast to 2032 (US)" report has been added to ResearchAndMarkets.com's offering.
  • This "Palmar Hyperhidrosis (US) - Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Palmar Hyperhidrosis (US) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The Palmar Hyperhidrosis (US) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries.
  • The Palmar Hyperhidrosis (US) epidemiology segment covers the epidemiology data from 2019 to 2032.